9-135695101-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001101677.2(SOHLH1):c.824C>T(p.Ala275Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000138 in 1,598,560 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001101677.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SOHLH1 | NM_001101677.2 | c.824C>T | p.Ala275Val | missense_variant | 6/8 | ENST00000425225.2 | NP_001095147.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOHLH1 | ENST00000425225.2 | c.824C>T | p.Ala275Val | missense_variant | 6/8 | 5 | NM_001101677.2 | ENSP00000404438.1 | ||
SOHLH1 | ENST00000298466.9 | c.824C>T | p.Ala275Val | missense_variant | 6/7 | 1 | ENSP00000298466.5 | |||
SOHLH1 | ENST00000673731.1 | c.182C>T | p.Ala61Val | missense_variant | 2/5 | ENSP00000501311.1 | ||||
SOHLH1 | ENST00000674066.1 | n.2414C>T | non_coding_transcript_exon_variant | 9/11 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152250Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000558 AC: 12AN: 215136Hom.: 0 AF XY: 0.0000423 AC XY: 5AN XY: 118078
GnomAD4 exome AF: 0.0000138 AC: 20AN: 1446192Hom.: 0 Cov.: 37 AF XY: 0.0000111 AC XY: 8AN XY: 718288
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152368Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74504
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at